满足
必赢亚洲团队
未来器官保存的经验与创新
The 必赢亚洲 leadership team brings a wealth of experience in the fields of organ transplantation, 临床研究, 医疗设备, and many others to our goal of improving the lives of transplant patients and their families around the world.
Dr. Waleed Hassanein founded 必赢亚洲 in 1998 to revolutionize organ transplant therapy for the treatment of end-stage lung, 心, 还有肝功能衰竭. Dr. Hassanein’s pioneering 临床研究 led to the development of an entirely new living organ preservation field for transplantation. 人体器官现在可以保持活力和功能(心脏跳动), 肺呼吸, 产生胆汁的肝脏, 等.) outside of the human body in 必赢亚洲’ revolutionary portable bwin必赢体育官网 (OCS™) technology. 在他的领导下, 必赢亚洲 has established itself as the global leader in living organ preservation and the OCS™ technology is becoming the new standard of care for solid organ transplantation. Dr. Hassanein was named as one of the top 50 Global Thinkers in Healthcare by Foreign Policy Magazine in 2015. He was the awardee of the Tribeca Disruptive Innovators Award in 2018 and was a finalist for the European Patent Office Inventor Award in 2017. Dr. Hassanein is a frequent guest speaker in national and international meetings on the future of organ preservation for transplantation. Dr. 哈桑内赢得了他的硕士学位.D. 来自乔治城大学医学院. 他在乔治城大学医学中心完成了两年的普通外科训练. He then completed a three-year cardiac surgery research fellowship at the West Roxbury VA Medical Center and Brigham and Women’s Hospital in Boston. 他对 体外 心 perfusion for transplantation was recognized by the American Association for Thoracic Surgery in 1998.
Stephen Gordon joined 必赢亚洲 in March of 2015 and leads our finance and accounting team. He has over 20 years of experience leading financial organizations within high technology and medical device companies. 在此期间，他关注的领域一直是战略规划&一个集成, 财务规划与分析, 改进量化信息的呈现. 在加入必赢亚洲之前，他是. 戈登是财务规划副总裁 & 在医疗设备和安全技术公司Analogic Corporation进行分析. 在加入Analogic之前，Mr. Gordon held various financial leadership positions at Hologic, Cytyc, Maxtor and Hewlett-Packard. Mr. Gordon earned a Bachelor’s degree in Finance and Accounting from The Wharton School at The University of Pennsylvania, 以及波士顿大学的MBA学位.
Dr. Khayal于2001年加入必赢亚洲. 在过去的18年里. Tamer Khayal assumed growing responsibilities to the current role of 首席商务官 in January 2018. From 2007-2018 he was the Chief Medical Officer leading 必赢亚洲’ global effort of building the clinical evidence, reimbursement initiatives and use model integration programs to support the PMA approvals and global commercial adoption of the Organ Care (OCS™) technology for lung, 心脏和肝脏移植. 他以病人为中心的做法开始商业化推广. Khayal赢得了全球OCS™用户的信任和尊重. 在加入必赢亚洲之前，他是. Khayal曾担任Zentiva中东医疗事务主任六年, 一家制药公司, 他在哪里领导临床研究, 监管文件和临床销售培训，为公司的ME&一个操作. Dr. Khayal received his MD degree from Cairo University School of Medicine and a General Certificate of Education from the University of London, 英格兰.
阿尼尔 Ranganath joins 必赢亚洲 with over 15 years of experience in the life sciences and biotechnology tools industries. 在加入必赢亚洲之前，他是. Ranganath served multiple roles of increasing scope and responsibility at Waters Corporation. 最近，Mr. Ranganath担任副总裁, 沃特斯公司副总法律顾问, 管理法律事务, 并担任沃特斯值得信赖的战略顾问, 战术, 以及运营计划. 他在Brown Rudnick LLP担任助理，开始了他的法律生涯, representing life sciences and biotechnology companies on corporate and intellectual property matters. Mr. Ranganath holds a Juris Doctorate from Suffolk University Law School and a Bachelor’s degree in Computer Science from Worcester Polytechnic Institute.
尼克·科克兰 joins 必赢亚洲 with over 20 years of experience in global supply chain and commercial operations. 在加入必赢亚洲之前，他是. Corcoran在Stryker Corporation担任多个职位. 最近，Mr. Corcoran曾担任Stryker Joint Replacement的部门运营副总裁, 管理部门的整个供应链, 包括内部生产基地和外部供应伙伴. 在斯瑞克的早期职业生涯中. Corcoran served as Vice President of Division and Commercial 操作 for the Spine Division, 部门运营高级总监, 全球采购总监. He also held a variety of Supply Chain and 操作 roles at Waters Corporation and Intel Corporation. Mr. Corcoran holds a bachelor’s degree in Finance and Economics from South East Technological University and a Master’s of Business in Supply Chain Management from The Smurfit School of Business, 都柏林大学学院.
Miriam Provost在医疗器械监管事务方面拥有超过24年的经验, 包括在食品和药物管理局工作了13年. 在加入必赢亚洲之前，他是. Provost was an internationally recognized expert in Regulatory Affairs and provided strategic guidance and 战术 support for large and small medical device companies as medical device regulatory consultant. Her expertise stems from 13 years as a reviewer and manager at the Food and Drug Administration where she served in a variety of roles across the Agency, 获得与FDA政策相关的广泛知识和熟悉度, 程序和决策. Dr. Provost earned a Bachelor’s degree in Chemical Engineering from the University of Dayton and M.S. 和Ph值.D. 获得宾夕法尼亚大学化学工程学位.
马克•安德森于2006年3月加入必赢亚洲. 他拥有超过15年的复杂产品开发和工程管理专业知识. Anderson has a proven record of bringing innovative Class II and Class III medical products to market, 包括器官灌注和心脏辅助装置. 在加入必赢亚洲之前，他是. 安德森担任R。&Teleflex公司的软件和电气工程经理.在那里，他领导的技术团队开发了下一代主动脉内球囊泵. He also held electrical and systems engineering roles developing submarine sonar systems for the Naval Undersea Warfare Center. Mr. Anderson earned a Bachelor’s degree in Electrical Engineering with a minor in Computer Science from Worcester Polytechnic Institute.
Laura joins 必赢亚洲 with over 20 years of experience leading clinical affairs teams in the conduct and execution of medical device clinical studies which have resulted in successful approvals. 在加入必赢亚洲之前, Laura曾担任Thoratec Corporation/Abbott的临床研究总监, 专门从事机械循环支持业务. Laura holds a Master of Public Health from the University of Michigan and received her nursing degree from Grand Valley State University.
必赢亚洲董事会和观察员
- 詹姆斯·R. 托宾
必赢亚洲董事会主席 - 爱德华M. 巴西莱
- 托马斯J. 甘德森
- Merilee雷恩斯
- Waleed Hassanein, m.sD
总裁兼首席执行官 - Edwin M. ,小.
- 大卫·威尔，m.s.D.
- 斯蒂芬妮·洛弗尔